How It Began
In March 2023, after a period of weakness, stomach aches, and strange symptoms, we took our daughter Romi, age 5, for a blood and urine test. That same day we got a phone call: “The results aren’t good – go to urgent care immediately.” From there we were sent to the hospital, where we heard the sentence: “This is an autoimmune disease. The immune system attacks the beta cells, they are destroyed and do not come back. You’ll need to learn to live with insulin.”
Like most families, we learned overnight how to manage a condition that never takes a day off – graphs, alarms, carb counting, and waking through the night to correct levels. We came to appreciate how much modern medicine helps: continuous glucose monitoring, pumps, and closed-loop systems have changed what life with Type 1 Diabetes can look like.
And still, one question refused to leave: if we can build technology that replaces part of the pancreas’s role – why not be equally ambitious about whether the biology itself can be helped to recover?
The Search
We did not settle for “there’s nothing to be done.” We began to search – everywhere. We read, consulted, and tested. At first to understand, and then to look for a path. Over three years, more than three thousand scientific papers were read and analyzed, alongside conversations with researchers and professionals in Israel and abroad.
The deeper we went, a different picture began to emerge from the one we heard at diagnosis. Not a one-dimensional, irreversible disease, but a complex system under stress – one that, under the right conditions, might be able to recover. SweetFreedom was born from that understanding: not as a rejection of medicine, and not as a promise of miracles, but as a disciplined refusal to accept that “management” is the end of the story.
Our Position
We do not oppose conventional care, and we do not compete with endocrinology. We do not offer medical advice or individualized treatment recommendations. We do something else: we ask whether Type 1 Diabetes has been framed too narrowly, and whether the ceiling of ambition has been set too low.
For decades, the narrative was simple: the immune system destroys beta cells, and the loss is irreversible. But emerging science suggests a more complex reality – beta cells under stress signal their own immune recruitment; gut changes precede autoimmunity; persistent viral signatures may sustain inflammation; the islet behaves as a whole system; and under certain conditions, regeneration appears possible. These are not fringe ideas – they are real signals across multiple research domains. SweetFreedom exists to connect them into a structured model, and to test it responsibly.
The Vision
We are building a structured restoration protocol for Type 1 Diabetes, and our vision is bold and specific:
By functional restoration we mean measurable recovery of the body’s own insulin production and improved metabolic stability. We are not claiming that we have already achieved this. We are claiming that the question deserves to be tested with rigor.
The Method: Disciplined Ambition
Where We Are Now
We are building a staged research pathway designed to test whether sequential biological restoration can produce measurable functional recovery. The immediate next step is a physician-supervised case series – 5-10 families with 12-month biomarker tracking. This stage is designed and ready to launch, and securing the funding to begin it is our immediate priority. One family is already implementing the protocol today.
The next stage is a Phase 2a clinical trial under a Principal Investigator with independent oversight. All of the work is designed to generate publication-grade data, with clinical leadership, biostatistical supervision, and longitudinal biomarker monitoring.
Who This Is For
- Strategic Partners – philanthropists and institutions prepared to fund rigorous tests of potentially transformative hypotheses.
- Clinical Collaborators – endocrinologists, immunologists, and researchers open to structured, regeneration-first investigation.
- Mission-Aligned Supporters – families and professionals who want responsible transparency, serious thinking, and real progress.
An Invitation
Type 1 Diabetes deserves more than better management. It deserves a serious attempt to test whether recovery is possible. If you are aligned with disciplined ambition – as a strategic partner, a professional, or a supporter – we invite you to connect.
